MedPath

Performance of Wearers of Stenfilcon A Contact Lenses After A Refit With Test Lenses

Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Test lens
Device: control lens
Registration Number
NCT03496701
Lead Sponsor
Coopervision, Inc.
Brief Summary

The aim of this study is to determine if habitual or adapted wearers of stenfilcon A control contact lenses can be refit into test lenses and be successful after one week of daily wear.

Detailed Description

This study is a prospective, multi-center, open label, bilateral, daily wear, one week dispensing study comparing performance of wearers of stenfilcon A control contact lenses after refit with test contact lenses.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
77
Inclusion Criteria

A person is eligible for inclusion in the study if he/she:

  • Is between 18 and 35 years of age (inclusive)
  • Has read and signed the informed consent letter
  • Is willing and anticipated to follow instructions and maintain the appointment schedule
  • Habitually wears soft spherical contact lenses with a power between -1.00D to -6.00D (inclusive) for a minimum 5 days per week, 10 hours per day and anticipates no difficulty wearing contact lenses for 7 days per week, 10 hours per day.
  • Habitually wears or is able to be adequately refit into MyDay Sphere lenses
  • Demonstrates an acceptable fit with the study lenses
  • Is correctable to a distance visual acuity of 0.20 logMAR (approximately 20/30) or better (in each eye) with the study contact lenses
  • Uses digital devices, (e.g. computer, tablet, smart phone, iPad), for more than 4 hours a day, 5 days a week.
  • Manifest cylindrical spectacle refraction does not exceed -0.75DC in either eye
  • Has clear corneas and no active ocular disease
  • Has a contact lens refraction that fits within the available parameters of the study lenses.
Exclusion Criteria

A person will be excluded from the study if he/she:

  • Is participating in any concurrent clinical research study

  • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)

  • Has a systemic condition that, in the opinion of the investigator, may affect the study measures

  • Is using any systemic or topical medications that in the opinion of the investigator may affect the study measures.

  • Presents with slit lamp findings or clinically significant anterior segment abnormalities that would contraindicate contact lens wear such as:

    • Pathological dry eye or associated findings
    • Significant pterygium, pinguecula, or corneal scars within the visual axis
    • Neovascularization > 0.75 mm in from of the limbus
    • Giant papillary conjunctivitis (GCP) worse than grade 1
    • Anterior uveitis or iritis (or history in past year)
    • Seborrheic eczema of eyelid region, Seborrheic conjunctivitis
    • History of corneal ulcers or fungal infections
    • Poor personal hygiene
  • Has a known history of corneal hypoesthesia (reduced corneal sensitivity)

  • Has a known sensitivity to the diagnostic pharmaceuticals to be used in the study

  • Has aphakia, keratoconus or a highly irregular cornea.

  • Has presbyopia or has dependence on spectacles for near work over the contact lenses.

  • Has undergone refractive surgery.

  • Is pregnant, lactating or planning a pregnancy (by verbal communication) at the time of enrollment

  • Has participated in any other type of eye related clinical or research study within the last 7 days

  • Is habitually using rewetting/ lubricating eye drops (more than once per day)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Stenfilcon A / Test lenscontrol lensAll subjects will first wear stenfilcon A contact lenses for one week, then refitted with test contact lenses to wear for one week.
Stenfilcon A / Test lensTest lensAll subjects will first wear stenfilcon A contact lenses for one week, then refitted with test contact lenses to wear for one week.
Primary Outcome Measures
NameTimeMethod
Overall Lens Fit Acceptance1 week on each study lenses

Overall lens fit acceptance on a scale of 0-4, 0.5 steps (Scale: 0=should not be worn, 4=perfect)

Secondary Outcome Measures
NameTimeMethod
Lens Centration1 week on each study lenses

Lens centration was assessed on a 3 point scale (1-Optimum, 2- Decentration acceptable, 3-Decentration unacceptable)

Post-blink Movement1 week on each study lenses

Post-blink movement assessed on a scale of 0-4, 1 step size (Scale: 0=Insufficient, 1=Minimal, 2=Optimal, 3=Moderate, 4=Excessive)

Trial Locations

Locations (4)

Nittany Eye Associates

🇺🇸

State College, Pennsylvania, United States

Golden Optometric Group

🇺🇸

Whittier, California, United States

Eric White, O.D., Inc.

🇺🇸

San Diego, California, United States

Golden Vision

🇺🇸

Sarasota, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath